Synovus Financial’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $2.34M | Sell |
21,094
-12
| -0.1% | -$1.36K | 0.03% | 336 |
|
|
2025
Q2 | $2.34M | Buy |
21,106
+1,320
| +7% | +$140K | 0.03% | 325 |
|
|
2025
Q1 | $2.22M | Buy |
19,786
+2,452
| +14% | +$253K | 0.03% | 333 |
|
|
2024
Q4 | $1.6M | Sell |
17,334
-19,931
| -53% | -$1.79M | 0.02% | 383 |
|
|
2024
Q3 | $3.12M | Buy |
37,265
+18,592
| +100% | +$1.42M | 0.04% | 308 |
|
|
2024
Q2 | $1.28M | Sell |
18,673
-35,002
| -65% | -$2.34M | 0.02% | 409 |
|
|
2024
Q1 | $3.93M | Buy |
53,675
+38,651
| +257% | +$2.97M | 0.05% | 221 |
|
|
2023
Q4 | $1.22M | Sell |
15,024
-45,992
| -75% | -$3.58M | 0.02% | 391 |
|
|
2023
Q3 | $4.57M | Sell |
61,016
-2,320
| -4% | -$178K | 0.05% | 203 |
|
|
2023
Q2 | $4.88M | Buy |
63,336
+47,587
| +302% | +$3.8M | 0.05% | 196 |
|
|
2023
Q1 | $1.31M | Buy |
15,749
+6,742
| +75% | +$558K | 0.01% | 402 |
|
|
2022
Q4 | $773K | Sell |
9,007
-1,193
| -12% | -$94.5K | 0.01% | 517 |
|
|
2022
Q3 | $626K | Sell |
10,200
-474
| -4% | -$29.9K | 0.01% | 523 |
|
|
2022
Q2 | $658K | Buy |
10,674
+77
| +0.7% | +$4.77K | 0.01% | 517 |
|
|
2022
Q1 | $631K | Sell |
10,597
-1,422
| -12% | -$90.9K | 0.01% | 553 |
|
|
2021
Q4 | $872K | Sell |
12,019
-3,763
| -24% | -$259K | 0.01% | 493 |
|
|
2021
Q3 | $1.1M | Sell |
15,782
-2,269
| -13% | -$159K | 0.01% | 412 |
|
|
2021
Q2 | $1.24M | Buy |
18,051
+1,875
| +12% | +$125K | 0.01% | 378 |
|
|
2021
Q1 | $1.04M | Sell |
16,176
-3,315
| -17% | -$214K | 0.01% | 380 |
|
|
2020
Q4 | $1.14M | Sell |
19,491
-2,550
| -12% | -$154K | 0.01% | 351 |
|
|
2020
Q3 | $1.4M | Sell |
22,041
-6,083
| -22% | -$422K | 0.02% | 302 |
|
|
2020
Q2 | $2.16M | Sell |
28,124
-12,862
| -31% | -$986K | 0.03% | 224 |
|
|
2020
Q1 | $3.06M | Buy |
40,986
+17,136
| +72% | +$1.18M | 0.04% | 204 |
|
|
2019
Q4 | $1.55M | Sell |
23,850
-533
| -2% | -$34.7K | 0.02% | 277 |
|
|
2019
Q3 | $1.55M | Sell |
24,383
-884
| -3% | -$57.8K | 0.02% | 268 |
|
|
2019
Q2 | $1.71M | Buy |
25,267
+595
| +2% | +$39.1K | 0.03% | 247 |
|
|
2019
Q1 | $1.61M | Sell |
24,672
-15,581
| -39% | -$1.04M | 0.03% | 248 |
|
|
2018
Q4 | $2.52M | Sell |
40,253
-52,974
| -57% | -$3.7M | 0.05% | 188 |
|
|
2018
Q3 | $7.21M | Sell |
93,227
-3,032
| -3% | -$229K | 0.11% | 117 |
|
|
2018
Q2 | $6.83M | Sell |
96,259
-7,055
| -7% | -$498K | 0.11% | 113 |
|
|
2018
Q1 | $7.79M | Buy |
103,314
+4,741
| +5% | +$377K | 0.13% | 105 |
|
|
2017
Q4 | $7.06M | Sell |
98,573
-933
| -0.9% | -$70.9K | 0.12% | 107 |
|
|
2017
Q3 | $8.05M | Buy |
99,506
+8,876
| +10% | +$679K | 0.15% | 94 |
|
|
2017
Q2 | $6.41M | Buy |
90,630
+2,475
| +3% | +$165K | 0.13% | 105 |
|
|
2017
Q1 | $5.98M | Buy |
88,155
+10,930
| +14% | +$769K | 0.13% | 106 |
|
|
2016
Q4 | $5.53M | Sell |
77,225
-10,948
| -12% | -$814K | 0.13% | 105 |
|
|
2016
Q3 | $7M | Buy |
88,173
+1,149
| +1% | +$93.3K | 0.16% | 89 |
|
|
2016
Q2 | $7.26M | Buy |
87,024
+5,737
| +7% | +$509K | 0.17% | 84 |
|
|
2016
Q1 | $7.47M | Sell |
81,287
-17,364
| -18% | -$1.57M | 0.18% | 78 |
|
|
2015
Q4 | $9.96M | Buy |
98,651
+7,307
| +8% | +$760K | 0.25% | 68 |
|
|
2015
Q3 | $8.99M | Buy |
91,344
+9,620
| +12% | +$1.07M | 0.24% | 66 |
|
|
2015
Q2 | $9.59M | Buy |
81,724
+176
| +0.2% | +$19.2K | 0.25% | 68 |
|
|
2015
Q1 | $8.02M | Sell |
81,548
-1,670
| -2% | -$170K | 0.21% | 76 |
|
|
2014
Q4 | $7.83M | Sell |
83,218
-1,044
| -1% | -$108K | 0.21% | 79 |
|
|
2014
Q3 | $8.98M | Buy |
84,262
+1,313
| +2% | +$129K | 0.25% | 69 |
|
|
2014
Q2 | $6.86M | Buy |
82,949
+42,279
| +104% | +$3.29M | 0.19% | 79 |
|
|
2014
Q1 | $2.88M | Sell |
40,670
-2,696
| -6% | -$211K | 0.08% | 133 |
|
|
2013
Q4 | $3.26M | Buy |
43,366
+2,102
| +5% | +$146K | 0.09% | 123 |
|
|
2013
Q3 | $2.6M | Sell |
41,264
-37,700
| -48% | -$2.25M | 0.08% | 132 |
|
|
2013
Q2 | $4.05M | Buy |
+78,964
| New | +$4.12M | 0.12% | 115 |
|
Other funds holding GILD
Synovus Financial's GILD Position: Q3 2025 in Review
Synovus Financial reduced its Gilead Sciences (GILD) stake by 0.06% in Q3 2025, selling an estimated $1.36K and leaving 21,094 shares worth $2.34M. The position accounts for 0.03% of the portfolio, ranked #336.
Synovus Financial first reported a position in GILD in Q2 2013 and has held it in 50 quarters since. The position peaked at $9.96M in Q4 2015. 2,026 funds tracked by Wall St. Rank hold GILD as of Q3 2025.
- Synovus Financial held 21,094 shares of Gilead Sciences worth $2.34M as of Q3 2025.
- Synovus Financial sold 12 Gilead Sciences shares in Q3 2025, an estimated $1.36K.
- Gilead Sciences made up 0.03% of Synovus Financial's portfolio in Q3 2025, its #336 holding.
- Synovus Financial first reported a position in Gilead Sciences in Q2 2013 and has held it in 50 quarters since.
- Synovus Financial's Gilead Sciences position peaked at $9.96M in Q4 2015.
- 2,026 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2025.
Based on Synovus Financial's 13F filing for Q3 2025, filed 7 Nov 2025.